soul trial oral semaglutide cardiovascular outcomes 2025 A emulation in Nature Medicine shows that treatment with and tirzepatide showed similar levels of benefit on in people at elevated cardiovascular risk with obesity and diabetes. Link SOUL findings highlight cardiovascular benefits

Clean ingredients and professional-quality products for everyday nutritional needs

If Medicaid coverage is delayed, denied, or limited in your state, understanding your genetic and biomarker context can support a more targeted discussion with your provider about alternative therapies, dosing strategies, and whether compounded GLP-1 optionsavailable through PlexusDx at affordable monthly ratesmay be appropriate for your clinical situation

Your care team can help you weigh comfort, expected results, and long-term consistency

The same volume at MOTS-c 10 mg/mL is 2 mg of MOTS-c

The BBD data were analyzed using contour and 3D plots to elucidate the independent variables' effects